1. Home
  2. GORO vs ANL Comparison

GORO vs ANL Comparison

Compare GORO & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Resource Corporation

GORO

Gold Resource Corporation

HOLD

Current Price

$1.53

Market Cap

250.9M

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

SELL

Current Price

$8.11

Market Cap

350.9M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
GORO
ANL
Founded
1998
2004
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Precious Metals
Sector
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
250.9M
350.9M
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
GORO
ANL
Price
$1.53
$8.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$1.75
$16.00
AVG Volume (30 Days)
3.3M
459.6K
Earning Date
04-16-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$65,726,000.00
N/A
Revenue This Year
$9.04
N/A
Revenue Next Year
$93.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.88
52 Week High
$1.87
$12.09

Technical Indicators

Market Signals
Indicator
GORO
ANL
Relative Strength Index (RSI) 51.86 52.82
Support Level $0.79 $1.36
Resistance Level $1.81 $12.09
Average True Range (ATR) 0.12 0.82
MACD -0.03 -0.47
Stochastic Oscillator 38.90 36.73

Price Performance

Historical Comparison
GORO
ANL

About GORO Gold Resource Corporation

Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: